SM_239a: Scleroderma Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Rodnan skin score is ____

A

Rodnan skin score is semi-quantitative measure of the extent of skin induration (fibrosis)

  • Normal skin: 0
  • Unable to pinch skin: 3+
  • Max score is 51 (because 17 sites)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

+ANA with _____ pattern is specific for systemic sclerosis

A

+ANA with nucleolar pattern is specific for systemic sclerosis

(note that ANA is positive in some healthy people)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe systemic sclerosis

A

Systemic sclerosis

  • Chronic multi-system disease
  • Orphan disease
  • Much more common in females, especially in post-childbearing years
  • Heterogeneous: multiple disease subsets or endophenotypes (diffuse cutaneous, limited cutaneous)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the major organ manifestations of systemic sclerosis

A

Systemic sclerosis

  • Two types: limited cutaneous and diffuse cutaneous
  • Oral, upper GI, lower GI, MSK, pulmonary, cardiac, renal, skin, and vascular
  • Small to medial vasculopathy in fingers -> digital necrosis
  • Severe hypomotility in GI
  • Watermelon stomach
  • Honeycombing or ground glass in lung
  • Onion skinning in kidney (no lumen left): increased ischemia, increased renin, and repeat
  • Soft tissue calcifications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe limited cutaneous systemic sclerosis

A

Limited cutaneous systemic sclerosis

  • CREST: calcinosis, Raynaud, esophageal involvement, sclerodactyly, telangiectasia
  • Antibody: anticentromere
  • Slow progression
  • Better prognosis
  • Long survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Limited cutaneous systemic sclerosis is also called ____ because of ____, ____, ____, ____, and ____

A

Limited cutaneous systemic sclerosis is also called CREST because of calcinosis, Raynaud, esophageal involvement, sclerodactyly, and telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Limited cutaneous systemic sclerosis antibody is ____

A

Limited cutaneous systemic sclerosis antibody is anticentromere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe diffuse cutaneous systemic sclerosis

A

Diffuse cutaneous systemic sclerosis

  • Diffuse skin induration
  • Truncal involvement
  • Antibody: anti-topoisomerase
  • Rapid progression
  • Poor prognosis
  • Poor survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diffuse cutaneous systemic sclerosis is ____

A

Diffuse cutaneous systemic sclerosis is anti-topoisomerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diffuse cutaneous systemic sclerosis has a ____ progression, ____ prognosis, and ____ survival than lateral cutaneous systemic sclerosis

A

Diffuse cutaneous systemic sclerosis has a more rapid progression, worse prognosis, and poorer survival than lateral cutaneous systemic sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Systemic sclerosis is characterized by ____ pathogenesis comprised of ____, ____, and ____

A

Systemic sclerosis is characterized by tripartite pathogenesis comprised of immune, vascular, and fibrotic

(vascular and fibrotic complications account for high mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe pathogenesis of systemic sclerosis

A

Systemic sclerosis pathogenesis

  • Microangiopathy (small blood vessels): Raynaud phenomenon, pulmonary arterial hypertension, scleroderma renal crisis, and mucocutaneous telangiectasia
  • Inflammation and autoimmunity: T cells, B cells, monocytes / macrophages, dendritic cells; cytokines, adipkines, chemokines; ANA, highly disease-specific autoantibodies
  • Fibrosis (scar) in multiple organs: skin, pulmonary, heart, GI, tendons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vascular pathogenesis of systemic sclerosis is _____

A

Vascular pathogenesis of systemic sclerosis is microangiopathy (small blood vessels)

  • Raynaud phenomenon
  • Pulmonary arterial hypertension
  • Scleroderma renal crisis
  • Mucocutaneous telangiectasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immune pathogenesis of systemic sclerosis involves ____ and ____

A

Immune pathogenesis of systemic sclerosis involves inflammation and autoimmunity

  • T cells, B cells, monocytes/macrophages, dendritic cells
  • Cytokines, adipokines, chemokines
  • Plasma cells: ANA, disease-specific autoantibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fibrotic pathogenesis in systemic sclerosis involves _____

A

Fibrotic pathogenesis in systemic sclerosis involves fibrosis in multiple organs

  • Skin fibrosis
  • Pulmonary fibrosis, also heart / GI / tendon fibrosi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe steps involved in systemic sclerosis pathogenesis on a cellular level

A

Systemic sclerosis pathogenesis

  1. Exposure (oxidative stress, virus, auto-antibodies, toxin) causes endothelial cell injury and apoptosis
  2. Impaired vasculogenesis, increased platelet activation and thrombus formation, ischemia-reperfusion injury leading to ROS generation, vasoconstrictors > vasodilators, impaired angiogenesis
  3. Increased adhesion molecules and anti-endothelial cell antibodies
  4. Increased fibroblast recruitment
  5. Increasec ollagen and other ECM proteins lead to late stage fibrosis
17
Q

Four cardinal manifestations of systemic sclerosis microangiopathy are ____, ____, ____, and ____

A

Four cardinal manifestations of systemic sclerosis microangiopathy are mucocutaneous telangiectasia, Raynaud phenomenon, pulmonary arterial hypertension, and scleroderma renal crisis

  • Scleroderma renal crisis: accelerated malignant HTN with microangiopathy, rapidly progressive oliguria, and chronic kidney disease
18
Q

____ Raynaud is more indicative of systemic sclerosis than ____

A

Secondary Raynaud is more indicative of systemic sclerosis than primary Raynaud

(secondary Raynaud indicative of ischemia)

19
Q

This is a _____

A

This is a telangiectasia

(manifestation of systemic sclerosis microangiopathy)

20
Q

_____ are indicative of avascularity in systemic sclerosis

A

Nailfold capillary changes are indicative of avascularity in systemic sclerosis

21
Q

Describe the phases of Raynaud phenomenon

A

Raynaud phenomenon (vasospasm of fingers)

  1. Trigger: cold exposure
  2. Blanching
  3. Cyanosis
  4. Can lead to ischemic finger ulcers: tip ulcers, mummification, and amputation
22
Q

Describe scleroderma renal crisis

A

Scleroderma renal crisis

  • Up to 15% of systemic sclerosis patients - more common in diffuse cutaneous systemic sclerosis
  • Acute hypertension
  • Malignant hypertension
  • Progressive oliguric renal failure
23
Q

Describe clinical presentation of scleroderma renal crisis

A

Scleroderma renal crisis clinical presentation

  • Accelerated / malignant hypertension
  • Stroke
  • Blindness
  • Heart attack
  • Heart failure
  • Kidney failure
  • 50% mortality at one year
24
Q

Pathogenesis of scleroderma renal crisis involves ____ and ____

A

Pathogenesis of scleroderma renal crisis involves renal ischemia and possibly intra-renal complement activation

(onion-skin vascular lesion, glomerular ischemia and collapse)

25
Q

Pathogenesis of scleroderma cycle involves a vicious cycle of repeatedly _____ and _____

A

Pathogenesis of scleroderma cycle involves a vicious cycle of repeatedly increased BP, increases plasma renin activity, and kidney damage

  • ACE inhibitors block ACE
  • ARBs block action of angiotesin II on AT1 receptor
  • Renin inhibitors (aliskiren) directly block renin
26
Q

Describe autoantibodies in systemic sclerosis

A

Systemic sclerosis autoantibodies

  • Serum antibodies (ANA, others) detected in >90% of systemic sclerosis patients: >8 antibodies, antibodies distinct from other autoimmune diseases
  • Mutually exclsuvie
  • Useful for diagnosis/classification/stratification: Scl-70 predicts lung disease / bad outcome, anti-centromere predicts relatively benign course, anti-RNA polymerase II increases renal crisis / cancer risk, Th/T0 predicts ILD
27
Q

Systemic sclerosis is uniquely defined by ____

A

Systemic sclerosis is uniquely defined by simultaneous multi-organ fibrosis

(liver not affected)

28
Q

Describe fibrosis in diffuse cutaneous systemic sclerosis

A

Diffuse cutaneous systemic sclerosis fibrosis

  • Skin - induration diffuse
  • Lung - ILD, NSIP or UIP patterns, leading cause of death
29
Q

Describe fibrotic tissue

A

Fibrotic tissue

  • Stiff/rigid
  • Shrunken
  • Pale
  • Irregular
30
Q

Describe the micro-structure of fibrotic structure

A

Micro-structure of fibrotic structure

  • Loss of architecture
  • ECMH accumulation
  • Capillary loss
  • Variable inflammation

Leads to loss of function

31
Q

Summarize systemic sclerosis

A

Systemic sclerosis

  • Multi-systemic disease with chronic and variable course, potentially lethal complications, and excess mortality
  • Complex pathogenesis (tripartite): vascular, inflammatory, fibrotic processes - cause unknown but genetics + environment